Literature DB >> 7611544

Diffuse idiopathic pulmonary neuroendocrine cell proliferation presenting as interstitial lung disease.

O A Armas1, D A White, R A Erlandson, J Rosai.   

Abstract

Pulmonary neuroendocrine cell (PNEC) hyperplasia typically occurs as an adaptive response in persons living at high altitudes and as a reactive response in the setting of lung injury. However, previous studies suggest that PNEC hyperplasia can occur in the absence of preexisting lung disease and may even give rise to airway disease through the development of pulmonary tumorlets and airway fibrosis and perhaps the release of paracrine secretions. We describe a patient with diffuse PNEC proliferation of a probable hyperplastic nature developing in the absence of a chronic pulmonary disorder who presented clinically with an interstitial lung process. Open lung biopsy displayed a florid intraepithelial population of PNEC diffusely involving the distal airways and alveoli with desquamation and filling of alveolar spaces by nests of PNEC. The presence of alveolar thickening was attributable to the intraepithelial proliferation of PNEC associated with interstitial fibrosis and accounted for mild reductions in the pulmonary diffusing capacity. The neuroendocrine differentiation of this proliferation was evident by light microscopic and ultrastructural examination. The absence of airway fibrosis and pulmonary tumorlets was in agreement with the lack of clinical airway disease in this case. The intraepithelial growth and absence of parenchymal invasion in this lesion favor a diffuse, florid PNEC hyperplasia with mild dysplastic features over a pulmonary neuroendocrine neoplasm.

Entities:  

Mesh:

Year:  1995        PMID: 7611544     DOI: 10.1097/00000478-199508000-00013

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Multidirectional differentiation of Achaete-Scute homologue-1-defined progenitors in lung development and injury repair.

Authors:  Yan Li; R Ilona Linnoila
Journal:  Am J Respir Cell Mol Biol       Date:  2012-08-09       Impact factor: 6.914

Review 2.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

3.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.

Authors:  Hanako Oba; Kazunori Nishida; Shingo Takeuchi; Hirohiko Akiyama; Koji Muramatsu; Masafumi Kurosumi; Toru Kameya
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

4.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

5.  Diffuse idiopathic neuroendocrine cell hyperplasia: an unusual cause of breathlessness and pulmonary nodules.

Authors:  V M Tippett; C G Wathen
Journal:  BMJ Case Rep       Date:  2010-12-01

Review 6.  The Ki-67 antigen in the new 2021 World Health Organization classification of lung neuroendocrine neoplasms.

Authors:  Giuseppe Pelosi; William D Travis
Journal:  Pathologica       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.